Effect of metformin on adverse outcomes in T2DM patients: Systemic review and meta-analysis of observational studies

Effect of metformin on adverse outcomes in T2DM patients: Systemic review and meta-analysis of observational studies

BackgroundThe cardiovascular protection effect of metformin on patients with type 2 diabetes mellitus (T2DM) remains inconclusive. This systemic review and meta-analysis were to estimate the effect of metformin on mortality and cardiovascular events among patients with T2DM.MethodsA search of the Pu...

Full description

Bibliographic Details
Main Authors:	Zhicheng Xu, Haidong Zhang, Chenghui Wu, Yuxiang Zheng, Jingzhou Jiang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	metformin type 2 diabetes mellitus adverse outcomes meta-analysis cardiovascular
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2022.944902/full

Similar Items

Metformin Use on Incidence and Oncologic Outcomes of Bladder Cancer Patients With T2DM: An Updated Meta-Analysis
by: Chen-Qian Liu, et al.
Published: (2022-04-01)

Association of metformin exposure with low risks of frailty and adverse outcomes in patients with diabetes
by: Pan Liu, et al.
Published: (2023-02-01)

Clinical Efficacy of Different Doses of Canagliflozin Combined with Metformin in the Treatment of Type 2 Diabetes Mellitus: a Meta-analysis
by: Yuying CHEN, Xiaodong LI, Yunzhao TANG, Daiqing LI
Published: (2022-05-01)

Association between organic cation transporter genetic polymorphisms and metformin response and intolerance in T2DM individuals: a systematic review and meta-analysis
by: Aiyu Peng, et al.
Published: (2023-07-01)

Effect and Safety of Adding Metformin to Insulin Therapy in Treating Adolescents With Type 1 Diabetes Mellitus: An Updated Meta-Analysis of 10 Randomized Controlled Trials
by: Ying Liu, et al.
Published: (2022-05-01)

Effects of Pre-hospital Metformin Use on Clinical Outcomes in Patients with Diabetes and Sepsis
by: HE Yufu, TONG Wenying, WANG Fang, LI Lixia, HE Junbing, SHAO Yiming
Published: (2024-03-01)

Metformin-Associated Lactic Acidosis: Predisposing Factors and Outcome
by: Min Ju Kim, et al.
Published: (2015-03-01)

The relationship between metformin consumption and cancer risk: An updated umbrella review of systematic reviews and meta-analyses
by: Farid Najafi, et al.
Published: (2023-01-01)

Analysis of Reports Sent to the Portuguese Pharmacovigilance System and Published Literature Regarding the Safety of Metformin in the Elderly
by: Beatriz Esteves, et al.
Published: (2023-08-01)

The relationship between the use of metformin and the risk of pancreatic cancer in patients with diabetes: a systematic review and meta-analysis
by: Jian Hu, et al.
Published: (2023-02-01)

Acarbose-metformin is more effective in glycemic variability control than repaglinide-metformin in T2DM patients inadequately controlled with metformin: a retrospective cohort study
by: Guoli Du, et al.
Published: (2020-10-01)

Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment
by: Tao Tao, et al.
Published: (2018-02-01)

The efficacy of Da Chaihu decoction combined with metformin tablets for type 2 diabetes mellitus: A systematic review and meta-analysis
by: Jia-bin Wang, et al.
Published: (2022-12-01)

Meta-analysis: The efficacy of metformin and other anti-hyperglycemic agents in prolonging the survival of hepatocellular carcinoma patients with type 2 diabetes
by: Jian Zhou, et al.
Published: (2020-05-01)

Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease
by: Te-Wei Ho, et al.
Published: (2019-04-01)

Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6
by: Mansoor Husain, et al.
Published: (2022-04-01)

Comparison of Vildagliptin-Metformin and Glimepiride-Metformin Treatments in Type 2 Diabetic Patients
by: Hyun Jeong Jeon, et al.
Published: (2011-10-01)

Neonatal outcomes in women with gestational diabetes mellitus treated with metformin in compare with insulin: A randomized clinical trial
by: Safura Ruholamin, et al.
Published: (2014-01-01)

Glycemic control and neonatal outcomes in women with gestational diabetes mellitus treated using glyburide, metformin, or insulin: a pairwise and network meta-analysis
by: Dan-Qing Yu, et al.
Published: (2021-10-01)

Sodium-glucose cotransporter 2 inhibitor versus metformin as first-line therapy in patients with type 2 diabetes mellitus: a multi-institution database study
by: Tien-Hsing Chen, et al.
Published: (2020-11-01)

Metformin Role in Diabetic Patients with Tuberculosis: a Review
by: Esravila Ariya Wibisono
Published: (2021-06-01)

ASSOCIATION OF VITAMIN B12 DEFICIENCY AND METFORMIN USE IN PATIENTS PRESENTING WITH TYPE II DIABETES MELLITUS
by: Karamat Ali, et al.
Published: (2020-10-01)

Severity of gastrointestinal side effects of metformin tablet compared to metformin capsule in type 2 diabetes mellitus patients
by: Mansour Siavash, et al.
Published: (2017-01-01)

The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes
by: Hyun Hee Chung, et al.
Published: (2013-04-01)

Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?
by: Ehtasham Ahmad, et al.
Published: (2020-11-01)

Impact of metformin on the risk and treatment outcomes of tuberculosis in diabetics: a systematic review
by: Xinyu Yu, et al.
Published: (2019-10-01)

Clinical effect of metformin in children and adolescents with type 2 diabetes mellitus: A systematic review and meta-analysis
by: Mohammed A Al-Shareef, et al.
Published: (2012-01-01)

Breast cancer risk for women with diabetes and the impact of metformin: A meta‐analysis
by: Yifan Lu, et al.
Published: (2023-05-01)

Dipeptidyl peptidase 4 (DPP-4) inhibitors and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM): a systematic review and meta-analysis
by: Dan Liu, et al.
Published: (2019-03-01)

Metformin is the most recognized first choice drug for patients with type 2 diabetes mellitus
by: A. M. Mkrtumyan
Published: (2018-03-01)

Combination of Metformin and Exercise in Management of Metabolic Abnormalities Observed in Type 2 Diabetes Mellitus
by: Jevtovic F
Published: (2021-09-01)

Therapeutic potential of metformin in normal glucose tolerant persons with metabolic syndrome
by: Petya Kamenova
Published: (2020-01-01)

Metformin Use and Risk of All-Cause Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease—A Systematic Review and Meta-Analysis
by: Yao Hu, et al.
Published: (2020-10-01)

Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies
by: Huoyan Liang, et al.
Published: (2019-02-01)

Adverse Pregnancy Outcomes and International Immigration Status: A Systematic Review and Meta-analysis
by: Samira Behboudi-Gandevani, et al.
Published: (2022-06-01)

Advantages of the use of metformin in patients with impaired uric acid metabolism
by: Maksim S. Eliseev, et al.
Published: (2021-05-01)

Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus with inadequate glycemic control on metformin: a meta-analysis
by: Zhang Jingfan, et al.

Association of metformin use with fracture risk in type 2 diabetes: A systematic review and meta-analysis of observational studies
by: Yining Wang, et al.
Published: (2023-01-01)

The effect of Chinese herbal formulas combined with metformin on modulating the gut microbiota in the amelioration of type 2 diabetes mellitus: A systematic review and meta-analysis
by: Yunxi Xu, et al.
Published: (2022-09-01)

Predictors for pharmacological therapy and perinatal outcomes with metformin treatment in women with gestational diabetes
by: Malgorzata M. Brzozowska, et al.
Published: (2023-01-01)